VivoSeq
Other

Hydrocortisone

0

Pipeline Programs

3

Active Trials

1

Companies Involved

Hydrocortisone is an early-stage landscape with 0 programs across 1 company. The most active players are US Oncology Research.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

27

clinical trials

Completed20 · 74%
Recruiting2 · 7%
Terminated2 · 7%
Not yet recruiting1 · 4%
Unknown status1 · 4%
Withdrawn1 · 4%

Trial Activity

27 trials

Hydrocortisone for BPD
Completed·NNICHD Neonatal Research Network·Phase 3·NCT01353313·800 enrolled
PTSD Prevention Using Oral Hydrocortisone
Completed··Phase 2·NCT04924166·201 enrolled
Administration of Hydrocortisone in Young Healthy Male Volunteers
Completed··Phase 4·NCT04137302·21 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)